Product Overview
Don’t wait a lifetime to launch a study that’s just “good enough”. Build and design a data collection experience that patients and sites will love to use.
See the benefits of an ePRO users truly enjoy.
Participants were screened and enrolled into the mental health study, consented remotely, and virtually onboarded into the ePRO experience. The GAD-7 was administered at multiple timepoints over a 12-week study design, with over 99% on-time survey completion.
Deploy hundreds of instruments at the highest quality standards.
Deliver an ePRO and eCOA experience at the highest standards. Capture accurate data exactly as you need it, and engage patients with a targeted notification campaign to make dropoff a thing of the past.
Deployment
- Web based
- Cloud Hosted
Pricing
- Subscription
- License Fee
More Information
Craft an experience that participants will love.
ePRO/eCOA is the heart of the participant experience, but it can be a lot more. Capabilities like appointment management, educational resources, transparency into your data, configurable portals, and more turn your ePRO/eCOA into a complete, rewarding experience
Stay on top of your study with the powerful reporting needed to run a study at scale.
Getting insight should be simple. Empower sites to stay on top of every patient’s status in the study and leverage powerful in-appnotifications and communication.
About the company
At Curebase, our mission is to bring quality medical innovations to patients faster and improve human wellbeing through more efficient clinical studies. We offer the full package of robust services and tools built in-house to run clinical studies end-to-end that reach more patients through in-home, community-based, and site-based care, leading to faster, cost effective, and diverse studies.
We are proving that clinical research can be radically accelerated if we empower physicians everywhere to enroll patients in the communities where they live. By applying cutting edge clinical software and remote study management techniques to the problem, we are reinventing clinical trials and research from the ground up.
